| This week's sponsor is CMIC Group. | | | |
Today's Rundown Henlius falls short of IPO goal, but still rakes in $410M on HKEX Themis raises €40M to run phase 3 chikungunya vaccine trial Amgen to bring Adaptive's MRD diagnostic to its wider blood cancer portfolio [Sponsored] Solutions to Today’s Biomanufacturing Challenges Versantis raises cash to take liver failure drug to clinical POC Biogen ramps up its SMA rivalry with Novartis with new Spinraza trial X4 Pharma founder Renato Skerlj signs on as its R&D chief Alexion replaces CFO Clancy and his 'legendary caution.' Could an M&A spree follow? Featured Story | | | Wednesday, September 18, 2019 Last week, Shanghai Henlius Biotech teed up for a $477 million IPO on the Hong Kong Stock Exchange. It fell a little short when it priced on Wednesday, ultimately bagging $410 million, but still made the top five biopharma IPOs so far this year. |
|
|---|
|
| This week's sponsor is Millipore Sigma. | | | |
Top Stories Wednesday, September 18, 2019 Themis has raised €40 million ($44 million). The Merck-backed series D positions Themis to take its chikungunya vaccine through a phase 3 trial and move the lead candidate from its immuno-oncology R&D program into humans. Wednesday, September 18, 2019 Amgen has tapped Adaptive Biotechnologies to deliver next-generation sequencing assays as it moves drugs toward approval. Under a four-year agreement, Adaptive’s clonoSEQ Assay will be used to assess minimal residual disease in clinical trials. Monday, September 16, 2019 With more complex molecules in development, changing capacity needs, uncertain forecasts and increased competition, the market demands flexibility and innovative approaches to address these challenges. Wednesday, September 18, 2019 Versantis has raised a €16 million series B round to gather clinical proof-of-concept data on a drug designed to clear out ammonia and other toxic metabolites that contribute to poor health outcomes in liver disease patients. Wednesday, September 18, 2019 In its latest gambit to preserve market share in spinal muscular atrophy, Biogen's launching a new Spinraza trial designed to determine whether a higher dose might be more effective than the one already FDA-approved. Wednesday, September 18, 2019 X4 Pharmaceuticals has a new R&D chief: Renato Skerlj, Ph.D., who founded the company alongside CEO Paula Ragan, Ph.D. and biotech luminary Henri Termeer. Skerlj joins X4 from Lysosomal Therapeutics, where he led drug discovery and preclinical development efforts. Wednesday, September 18, 2019 When Paul Clancy jumped ship from Biogen to become Alexion’s chief financial officer in 2017, he was touted as a “careful steward” by top brass after the company's troubled past. Now, the careful steward is gone, and an M&A spree could be on the horizon. | This week's sponsor is LabConnect. | | |
LabConnect is the preeminent provider of central laboratory support services for logistically and analytically complex studies - customizable to meet the unique needs of your clinical trials. We are your connection to confidence. Contact us today. |
Enrollment Showcase | | | October 23-25, 2019 | Chicago, IL | Presented by Biotech Primer BioImmersion: Biotech for the Non-Scientist is a three-day, in-depth course that delves into the scientific details on a broad number of biotechnology topics. Register today! |
|
|---|
|
Resources Sponsored by: BioAnalytix Download the White Paper and learn how detailed characterization can guide successful development of gene therapy products. Sponsored by: Blue Matter, strategic consultants in the life sciences White paper providing an overview of precision medicine in oncology, as well as a look ahead at future developments and keys to success for pharmaceutical and diagnostics companies. Sponsored by: Patheon, by Thermo Fisher Scientific Avoid potential risks to the patient as well as costly interruptions during development. Sponsored by: Outer Edge Technology Find out how outsourcing your IT requirements enhances the bottom line while creating strategic advantage. Sponsored by: Vineti Developing a cell therapy, gene therapy, or personalized cancer vaccine? Modern data management makes a critical difference in operational and regulatory outcomes. This whitepaper will help your team leverage the latest data strategies for success. Sponsored by: AlphaSense AI-powered research tools are making it easier to source confident healthcare market intelligence with accuracy and efficiency -- download now to learn more about improving your competitive research strategy. Sponsored by: Elemental Machines Your lab is talking to you, are you listening? Sponsored by: Frenova Want to be sure your renal research protocol design is fit for the real world? Sponsored by: Recro Gainesville Vetting CDMOs but unsure what to look for in prospective partners’ multiproduct facilities? Sponsored by: Accenture Clinical trials are one of the pharma industry’s most painful and costly processes. Read how technology could transform the trial process from nine years to a matter of hours. Sponsored by: Baxter BioPharma Solutions Check out Baxter BioPharma Solutions’ whitepaper to learn considerations and options for developing a product in a prefilled syringe. Sponsored by: Alexander Group From sales headcount and budgets to new product launches and saying “yes” to millennials, hear the top 7 topics that are trending in sales compensation. Sponsored by: Kinaxis Download this life sciences industry spotlight to discover how concurrent planning can help you overcome complex supply chain challenges to drive down costs and improve efficiency. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. U.S. Healthcare Compliance Certificate Program October 14-17, 2019 | Newark, New Jersey European Healthcare Compliance Certificate Program October 21-25, 2019 | Paris, France BioBasics: Biotech For The Non-Scientist Oct 22-23, 2019 | San Diego, CA BioImmersion: Biotech for the Non-Scientist October 23-25, 2019 | Chicago, IL 4th FierceBiotech Drug Development Forum October 28-29, 2019 | Boston, MA Drug Development Immersion November 7-8, 2019 | Boston, MA Advanced Therapies: Immunotherapies, Cell Therapies and Gene Therapies November 15, 2019 | Boston, MA Drug Development Boot Camp® 2019 November 20-21, 2019 | Boston, MA | Register NOW and start Pre-Boot Camp Preparation! | 